<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Bayer Company News via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Bayer Company News' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Bayer+Company+News&t=Bayer+Company+News&s=Search&f=source]]></link>
        <lastBuildDate>Fri, 19 Mar 2010 16:14:26 +0100</lastBuildDate>
        <item>
            <title>Bayer MaterialScience acquires Artificial Muscle, Inc.</title>
            <link>http://www.medworm.com/index.php?rid=3345056&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Enabling technology for the next generation of touchscreens (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3345056</comments>
            <pubDate>Tue, 09 Mar 2010 08:45:00 +0100</pubDate>
            <guid isPermaLink="false">3345056</guid>        </item>
        <item>
            <title>Bayer Helps Victims of Earthquake in Chile</title>
            <link>http://www.medworm.com/index.php?rid=3333542&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>100,000 Dollar Donation for Aid Campaign &amp;#8220;Chile helps Chile&amp;#8221; (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3333542</comments>
            <pubDate>Fri, 05 Mar 2010 13:50:00 +0100</pubDate>
            <guid isPermaLink="false">3333542</guid>        </item>
        <item>
            <title>Bayer successful in a difficult environment</title>
            <link>http://www.medworm.com/index.php?rid=3309587&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Group sales EUR 31,168 million (minus 5.3 percent) / EBITDA before special items EUR 6,472 million (minus 6.6 percent) / Net income EUR 1,359 million (minus 20.9 percent) / Net cash flow significantly improved to EUR 5,375 million (plus 49 percent) / Net financial debt reduced by EUR 4.5 billion to EUR 9.7 billion / Core earnings per share expected to improve by about 10 percent in 2010 (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3309587</comments>
            <pubDate>Fri, 26 Feb 2010 06:31:00 +0100</pubDate>
            <guid isPermaLink="false">3309587</guid>        </item>
        <item>
            <title>Bayer modifies Board of Management compensation system</title>
            <link>http://www.medworm.com/index.php?rid=3309588&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Reduction of short-term incentive and strengthening of long-term compensation component / Extended share retention period under long-term incentive program / Increased personal investment in Bayer stock / Adjustments effective January 1, 2010 / Compensation system to be submitted to Annual Stockholders&amp;#8217; Meeting for approval (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3309588</comments>
            <pubDate>Fri, 26 Feb 2010 06:30:00 +0100</pubDate>
            <guid isPermaLink="false">3309588</guid>        </item>
        <item>
            <title>Bayer proposes dividend for 2009 of EUR 1.40 per share</title>
            <link>http://www.medworm.com/index.php?rid=3300371&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3300371</comments>
            <pubDate>Wed, 24 Feb 2010 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">3300371</guid>        </item>
        <item>
            <title>Ehrfeld Mikrotechnik BTS and Lonza cooperate in the microreactor technology</title>
            <link>http://www.medworm.com/index.php?rid=3286061&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Ehrfeld Mikrotechnik BTS, a Bayer Technology Services company, to exclusively manufacture and market Lonza microreactors / Joint forces to develop green chemical syntheses (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3286061</comments>
            <pubDate>Fri, 19 Feb 2010 06:30:00 +0100</pubDate>
            <guid isPermaLink="false">3286061</guid>        </item>
        <item>
            <title>VEGF Trap-Eye Shows Positive Results in Phase II Study in Patients with Diabetic Macular Edema</title>
            <link>http://www.medworm.com/index.php?rid=3281795&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Statistically significant improvement in vision achieved over 24 weeks / Results to be presented at the Angiogenesis 2010 &amp;#8211; Clinical Trials meeting in Miami, Florida on February 20, 2010 (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3281795</comments>
            <pubDate>Thu, 18 Feb 2010 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">3281795</guid>        </item>
        <item>
            <title>Bayer starts clinical Phase I study with personalized vaccine from tobacco plants</title>
            <link>http://www.medworm.com/index.php?rid=3214746&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Idiotype vaccination in the treatment of non-Hodgkin&amp;#8217;s lymphoma (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3214746</comments>
            <pubDate>Thu, 28 Jan 2010 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">3214746</guid>        </item>
        <item>
            <title>Masdar and Bayer MaterialScience sign co-operation on sustainable construction</title>
            <link>http://www.medworm.com/index.php?rid=3206974&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Bayer MaterialScience to implement EcoCommercial building program in Masdar City to highlight energy-efficient and economic construction in subtropical climate (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3206974</comments>
            <pubDate>Tue, 26 Jan 2010 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">3206974</guid>        </item>
        <item>
            <title>Bayer Helps Victims of Earthquake in Haiti</title>
            <link>http://www.medworm.com/index.php?rid=3177790&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Medicines Donated as Immediate Relief (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3177790</comments>
            <pubDate>Fri, 15 Jan 2010 17:00:00 +0100</pubDate>
            <guid isPermaLink="false">3177790</guid>        </item>
        <item>
            <title>Clinical Programs with Riociguat in Pulmonary Hypertension Well on Track</title>
            <link>http://www.medworm.com/index.php?rid=3073739&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Encouraging top-line data from the first Phase II study in pulmonary hypertension owing to interstitial lung disease (PH-ILD) / First Phase II study in pulmonary hypertension owing to chronic obstructive pulmonary disease (PH-COPD) successfully completed (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3073739</comments>
            <pubDate>Thu, 10 Dec 2009 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3073739</guid>        </item>
        <item>
            <title>Visanne® cleared for market launch in Europe as new treatment option for endometriosis</title>
            <link>http://www.medworm.com/index.php?rid=3062380&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3062380</comments>
            <pubDate>Mon, 07 Dec 2009 07:30:00 +0100</pubDate>
            <guid isPermaLink="false">3062380</guid>        </item>
        <item>
            <title>Phase III EINSTEIN-Extension Study of Bayer’s Rivaroxaban Shows Significant Benefit in the Prevention of Secondary Symptomatic VTE</title>
            <link>http://www.medworm.com/index.php?rid=3060697&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Discussions with FDA on Complete Response Letter for VTE Prevention After Total Knee and Hip Replacement Surgery (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3060697</comments>
            <pubDate>Sun, 06 Dec 2009 13:59:00 +0100</pubDate>
            <guid isPermaLink="false">3060697</guid>        </item>
        <item>
            <title>Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President</title>
            <link>http://www.medworm.com/index.php?rid=3050483&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>German Federal President Horst Köhler praises outstanding innovation achievement / Development of the novel oral anticoagulant rivaroxaban commended (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3050483</comments>
            <pubDate>Wed, 02 Dec 2009 19:45:00 +0100</pubDate>
            <guid isPermaLink="false">3050483</guid>        </item>
        <item>
            <title>Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy</title>
            <link>http://www.medworm.com/index.php?rid=3042455&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3042455</comments>
            <pubDate>Tue, 01 Dec 2009 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">3042455</guid>        </item>
        <item>
            <title>Bayer’s Betaferon® approved in China for Treatment of Multiple Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=3042456&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Launch planned by mid 2010 (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3042456</comments>
            <pubDate>Tue, 01 Dec 2009 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">3042456</guid>        </item>
        <item>
            <title>Bayer Starts Phase III Trial with Florbetaben</title>
            <link>http://www.medworm.com/index.php?rid=3038230&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Detection of beta-Amyloid plaques in Alzheimer patients possible / Florbetaben could improve current diagnostic tools (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3038230</comments>
            <pubDate>Mon, 30 Nov 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">3038230</guid>        </item>
        <item>
            <title>Bayer receives European environment award for its vehicle fleet</title>
            <link>http://www.medworm.com/index.php?rid=3032499&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3032499</comments>
            <pubDate>Fri, 27 Nov 2009 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">3032499</guid>        </item>
        <item>
            <title>Bayer strengthens sustainability commitment</title>
            <link>http://www.medworm.com/index.php?rid=2979549&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Focus on the fields of health care, nutrition and climate protection / Eight lighthouse projects: More than 15 million people benefit directly / New technologies to reduce greenhouse gas emissions by five million metric tons per year / Management Board Chairman Wenning: &amp;#8220;We are making specific contributions to balance commercial success with the protection of the environment and the needs of society&amp;#8221; (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2979549</comments>
            <pubDate>Wed, 11 Nov 2009 08:59:00 +0100</pubDate>
            <guid isPermaLink="false">2979549</guid>        </item>
        <item>
            <title>Bayer CropScience completes acquisition of biotech company Athenix Corp.</title>
            <link>http://www.medworm.com/index.php?rid=2949501&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Purchase price of USD 365 million plus milestones (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2949501</comments>
            <pubDate>Mon, 02 Nov 2009 14:30:00 +0100</pubDate>
            <guid isPermaLink="false">2949501</guid>        </item>
        <item>
            <title>Bayer back on the uptrend</title>
            <link>http://www.medworm.com/index.php?rid=2929507&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>HealthCare again strong &amp;#8211; weak quarter at CropScience &amp;#8211; MaterialScience substantially improved / Group sales EUR 7,392 million (minus 7.0 percent) / EBITDA before special items EUR 1,499 million (plus 0.4 percent) / Net income EUR 249 million (minus 10.1 percent) / Net cash flow EUR 1,517 million (plus 22.9 percent) / Full-year Group forecast confirmed (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2929507</comments>
            <pubDate>Tue, 27 Oct 2009 06:30:00 +0100</pubDate>
            <guid isPermaLink="false">2929507</guid>        </item>
        <item>
            <title>Bayer Early Excellence in Science Award 2009: EUR 30,000 for young research scientists</title>
            <link>http://www.medworm.com/index.php?rid=2918420&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>Dr. Jürgen Groll (RWTH Aachen) awarded prize in the &amp;#8220;Materials&amp;#8221; field / Dr. Noriyuki Nishimura (University of California, San Diego, United States) honored in the &amp;#8220;Biology&amp;#8221; category / Dr. Tobias Ritter (Harvard University, United States) winner of the award for &amp;#8220;Chemistry&amp;#8221; (Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918420</comments>
            <pubDate>Fri, 23 Oct 2009 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">2918420</guid>        </item>
        <item>
            <title>The risk of venous thromboembolism for drospirenone containing oral contraceptives is comparable to the risk of other oral contraceptives available on the market</title>
            <link>http://www.medworm.com/index.php?rid=2918421&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918421</comments>
            <pubDate>Thu, 22 Oct 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2918421</guid>        </item>
        <item>
            <title>Bayer MaterialScience AG ends reduced working hours at German sites</title>
            <link>http://www.medworm.com/index.php?rid=2878166&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2878166</comments>
            <pubDate>Fri, 09 Oct 2009 17:00:00 +0100</pubDate>
            <guid isPermaLink="false">2878166</guid>        </item>
        <item>
            <title>Bayer CropScience first to sequence the entire genome of rapeseed/canola</title>
            <link>http://www.medworm.com/index.php?rid=2874184&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2874184</comments>
            <pubDate>Fri, 09 Oct 2009 08:55:00 +0100</pubDate>
            <guid isPermaLink="false">2874184</guid>        </item>
        <item>
            <title>Nexavar® in Combination with Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival</title>
            <link>http://www.medworm.com/index.php?rid=2822567&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2822567</comments>
            <pubDate>Wed, 23 Sep 2009 10:30:00 +0100</pubDate>
            <guid isPermaLink="false">2822567</guid>        </item>
        <item>
            <title>Bayer researchers nominated for the “Deutscher Zukunftspreis” awarded by the German Federal President</title>
            <link>http://www.medworm.com/index.php?rid=2817458&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2817458</comments>
            <pubDate>Tue, 22 Sep 2009 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">2817458</guid>        </item>
        <item>
            <title>Bayer honored as world’s best company in climate protection</title>
            <link>http://www.medworm.com/index.php?rid=2817459&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2817459</comments>
            <pubDate>Tue, 22 Sep 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2817459</guid>        </item>
        <item>
            <title>Bayer’s Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=2817460&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2817460</comments>
            <pubDate>Tue, 22 Sep 2009 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">2817460</guid>        </item>
        <item>
            <title>Bayer CropScience accelerates expansion of biotech and seed business with investments of around EUR 3.5 billion through 2018</title>
            <link>http://www.medworm.com/index.php?rid=2802638&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2802638</comments>
            <pubDate>Thu, 17 Sep 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2802638</guid>        </item>
        <item>
            <title>Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010</title>
            <link>http://www.medworm.com/index.php?rid=2795085&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2795085</comments>
            <pubDate>Tue, 15 Sep 2009 08:18:00 +0100</pubDate>
            <guid isPermaLink="false">2795085</guid>        </item>
        <item>
            <title>Bayer remains “best in class” in sustainability</title>
            <link>http://www.medworm.com/index.php?rid=2764557&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2764557</comments>
            <pubDate>Fri, 04 Sep 2009 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">2764557</guid>        </item>
        <item>
            <title>Bayer and Algeta Enter Global Agreement for Development and Commercialization of Treatment for Bone Metastases in Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=2760477&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2760477</comments>
            <pubDate>Thu, 03 Sep 2009 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">2760477</guid>        </item>
        <item>
            <title>Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S.</title>
            <link>http://www.medworm.com/index.php?rid=2755437&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2755437</comments>
            <pubDate>Wed, 02 Sep 2009 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">2755437</guid>        </item>
        <item>
            <title>Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF)</title>
            <link>http://www.medworm.com/index.php?rid=2746954&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2746954</comments>
            <pubDate>Sun, 30 Aug 2009 15:00:00 +0100</pubDate>
            <guid isPermaLink="false">2746954</guid>        </item>
        <item>
            <title>Children’s pictures challenge climate change</title>
            <link>http://www.medworm.com/index.php?rid=2714465&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2714465</comments>
            <pubDate>Thu, 20 Aug 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2714465</guid>        </item>
        <item>
            <title>Bayer CropScience acquires US biotech company Athenix Corp.</title>
            <link>http://www.medworm.com/index.php?rid=2714466&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2714466</comments>
            <pubDate>Wed, 19 Aug 2009 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">2714466</guid>        </item>
        <item>
            <title>New Levitra® formulation submitted for registration in the EU</title>
            <link>http://www.medworm.com/index.php?rid=2710869&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2710869</comments>
            <pubDate>Wed, 19 Aug 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2710869</guid>        </item>
        <item>
            <title>Bayer robust in a difficult environment</title>
            <link>http://www.medworm.com/index.php?rid=2647595&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2647595</comments>
            <pubDate>Wed, 29 Jul 2009 11:33:16 +0100</pubDate>
            <guid isPermaLink="false">2647595</guid>        </item>
        <item>
            <title>Nexavar® in Combination with Chemotherapy Shown To Extend Progression-Free Survival in Patients with Advanced Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2628614&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2628614</comments>
            <pubDate>Wed, 22 Jul 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2628614</guid>        </item>
        <item>
            <title>Bayer CropScience expands global R&amp;D activities in seeds and traits by setting up new research focus area in cereals</title>
            <link>http://www.medworm.com/index.php?rid=2636689&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2636689</comments>
            <pubDate>Tue, 21 Jul 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2636689</guid>        </item>
        <item>
            <title>Bayer CropScience expands global R&amp;D activities in seeds and traits by setting up new research focus area in cereals</title>
            <link>http://www.medworm.com/index.php?rid=2618805&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2618805</comments>
            <pubDate>Tue, 21 Jul 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2618805</guid>        </item>
        <item>
            <title>Bayer MaterialScience lifts force majeure for TDI in Europe</title>
            <link>http://www.medworm.com/index.php?rid=2604465&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2604465</comments>
            <pubDate>Thu, 16 Jul 2009 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">2604465</guid>        </item>
        <item>
            <title>Bayer presents positive Phase II data with florbetaben</title>
            <link>http://www.medworm.com/index.php?rid=2593997&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2593997</comments>
            <pubDate>Mon, 13 Jul 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2593997</guid>        </item>
        <item>
            <title>Bayer acquires exclusive rights to Bioton’s insulin SciLin®</title>
            <link>http://www.medworm.com/index.php?rid=2582627&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2582627</comments>
            <pubDate>Thu, 09 Jul 2009 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">2582627</guid>        </item>
        <item>
            <title>Bayer submits first-in-class estradiol-based oral contraceptive for approval in the U.S.</title>
            <link>http://www.medworm.com/index.php?rid=2578807&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2578807</comments>
            <pubDate>Wed, 08 Jul 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2578807</guid>        </item>
        <item>
            <title>Bayer MaterialScience declares force majeure for TDI in Europe</title>
            <link>http://www.medworm.com/index.php?rid=2578808&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2578808</comments>
            <pubDate>Tue, 07 Jul 2009 15:30:00 +0100</pubDate>
            <guid isPermaLink="false">2578808</guid>        </item>
        <item>
            <title>Bayer files patent infringement lawsuit against Teva</title>
            <link>http://www.medworm.com/index.php?rid=2566801&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2566801</comments>
            <pubDate>Wed, 01 Jul 2009 21:50:00 +0100</pubDate>
            <guid isPermaLink="false">2566801</guid>        </item>
        <item>
            <title>Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canola</title>
            <link>http://www.medworm.com/index.php?rid=2551770&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2551770</comments>
            <pubDate>Mon, 29 Jun 2009 15:53:43 +0100</pubDate>
            <guid isPermaLink="false">2551770</guid>        </item>
        <item>
            <title>Bayer CropScience and DuPont expand collaboration with broad license agreements</title>
            <link>http://www.medworm.com/index.php?rid=2514359&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2514359</comments>
            <pubDate>Thu, 25 Jun 2009 14:27:20 +0100</pubDate>
            <guid isPermaLink="false">2514359</guid>        </item>
        <item>
            <title>Bayer Technology Services completed sulfuric acid plant featuring innovative technology</title>
            <link>http://www.medworm.com/index.php?rid=2481989&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2481989</comments>
            <pubDate>Tue, 16 Jun 2009 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">2481989</guid>        </item>
        <item>
            <title>Bayer HealthCare and Genzyme Finalize Strategic Alliance Agreement</title>
            <link>http://www.medworm.com/index.php?rid=2451052&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2451052</comments>
            <pubDate>Tue, 02 Jun 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2451052</guid>        </item>
        <item>
            <title>Bayer and Onyx Initiate Phase III Trial of Nexavar® in Non-small Cell Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2451053&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2451053</comments>
            <pubDate>Mon, 01 Jun 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2451053</guid>        </item>
        <item>
            <title>Bayer Schering Pharma Announces New Data on Novel Anti-cancer Compound BAY 73-4506</title>
            <link>http://www.medworm.com/index.php?rid=2444788&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2444788</comments>
            <pubDate>Sat, 30 May 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2444788</guid>        </item>
        <item>
            <title>U.S. FDA Issues Complete Response Letter for Rivaroxaban</title>
            <link>http://www.medworm.com/index.php?rid=2444789&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2444789</comments>
            <pubDate>Thu, 28 May 2009 17:30:00 +0100</pubDate>
            <guid isPermaLink="false">2444789</guid>        </item>
        <item>
            <title>Phase III Trial Started to Evaluate Combination Therapy of Nexavar® and Tarceva® in Patients with Liver Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2444790&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2444790</comments>
            <pubDate>Thu, 28 May 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2444790</guid>        </item>
        <item>
            <title>Bayer: Successful and sustainable business</title>
            <link>http://www.medworm.com/index.php?rid=2435245&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2435245</comments>
            <pubDate>Tue, 26 May 2009 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">2435245</guid>        </item>
        <item>
            <title>U.S. Department of Agriculture grants approval for Bayer CropScience’s GlyTol™ cotton technology</title>
            <link>http://www.medworm.com/index.php?rid=2430436&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2430436</comments>
            <pubDate>Fri, 22 May 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2430436</guid>        </item>
        <item>
            <title>Nexavar® Approved in Japan for the Treatment of Advanced Liver Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2425732&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2425732</comments>
            <pubDate>Wed, 20 May 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2425732</guid>        </item>
        <item>
            <title>Bayer Schering Pharma presents positive results of phase II study with Riociguat</title>
            <link>http://www.medworm.com/index.php?rid=2420397&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2420397</comments>
            <pubDate>Tue, 19 May 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2420397</guid>        </item>
        <item>
            <title>Qlaira® – innovative estradiol-based oral contraceptive available in Europe from May onwards</title>
            <link>http://www.medworm.com/index.php?rid=2409879&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2409879</comments>
            <pubDate>Thu, 14 May 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2409879</guid>        </item>
        <item>
            <title>“Corporate strategy proves effective in a difficult environment”</title>
            <link>http://www.medworm.com/index.php?rid=2409880&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2409880</comments>
            <pubDate>Tue, 12 May 2009 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">2409880</guid>        </item>
        <item>
            <title>Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch</title>
            <link>http://www.medworm.com/index.php?rid=2394473&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2394473</comments>
            <pubDate>Tue, 05 May 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2394473</guid>        </item>
        <item>
            <title>Bayer and Regeneron extend development program for VEGF Trap-Eye</title>
            <link>http://www.medworm.com/index.php?rid=2378856&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2378856</comments>
            <pubDate>Thu, 30 Apr 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2378856</guid>        </item>
        <item>
            <title>CropScience and Pharmaceuticals continue on a path of growth – Slump in business at MaterialScience leaves a distinct mark</title>
            <link>http://www.medworm.com/index.php?rid=2378857&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2378857</comments>
            <pubDate>Wed, 29 Apr 2009 07:30:00 +0100</pubDate>
            <guid isPermaLink="false">2378857</guid>        </item>
        <item>
            <title>Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors for the Treatment of Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2372111&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2372111</comments>
            <pubDate>Tue, 28 Apr 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2372111</guid>        </item>
        <item>
            <title>Phase III Trial of Nexavar® in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint</title>
            <link>http://www.medworm.com/index.php?rid=2372112&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2372112</comments>
            <pubDate>Mon, 27 Apr 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2372112</guid>        </item>
        <item>
            <title>Bayer CropScience invests EUR 30 million in expansion of crop protection production at the Dormagen Chemical Park</title>
            <link>http://www.medworm.com/index.php?rid=2357086&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2357086</comments>
            <pubDate>Fri, 03 Apr 2009 17:06:00 +0100</pubDate>
            <guid isPermaLink="false">2357086</guid>        </item>
        <item>
            <title>Bayer HealthCare and Genzyme Corporation Enter New Strategic Agreement</title>
            <link>http://www.medworm.com/index.php?rid=2314010&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2314010</comments>
            <pubDate>Tue, 31 Mar 2009 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2314010</guid>        </item>
        <item>
            <title>Bayer CropScience has acquired certain AgroGreenŽs biological products for the crop protection business</title>
            <link>http://www.medworm.com/index.php?rid=2314011&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2314011</comments>
            <pubDate>Tue, 31 Mar 2009 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">2314011</guid>        </item>
        <item>
            <title>Bayer MaterialScience builds new manufacturing facility for polyurethane raw materials in India</title>
            <link>http://www.medworm.com/index.php?rid=2314012&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2314012</comments>
            <pubDate>Thu, 26 Mar 2009 15:00:00 +0100</pubDate>
            <guid isPermaLink="false">2314012</guid>        </item>
        <item>
            <title>Energy efficiency expert Jochem wins “Bayer Climate Award”</title>
            <link>http://www.medworm.com/index.php?rid=2290685&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2290685</comments>
            <pubDate>Tue, 24 Mar 2009 10:02:00 +0100</pubDate>
            <guid isPermaLink="false">2290685</guid>        </item>
        <item>
            <title>U.S. FDA Advisory Committee supports favorable benefit-risk profile of Bayer’s rivaroxaban</title>
            <link>http://www.medworm.com/index.php?rid=2279685&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2279685</comments>
            <pubDate>Thu, 19 Mar 2009 22:40:00 +0100</pubDate>
            <guid isPermaLink="false">2279685</guid>        </item>
        <item>
            <title>Bayer: corporate strategy proves effective in a difficult environment</title>
            <link>http://www.medworm.com/index.php?rid=2232300&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2232300</comments>
            <pubDate>Tue, 03 Mar 2009 07:30:00 +0100</pubDate>
            <guid isPermaLink="false">2232300</guid>        </item>
        <item>
            <title>Bayer proposes increased dividend for 2008 of EUR 1.40 per share</title>
            <link>http://www.medworm.com/index.php?rid=2222354&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2222354</comments>
            <pubDate>Fri, 27 Feb 2009 13:35:00 +0100</pubDate>
            <guid isPermaLink="false">2222354</guid>        </item>
        <item>
            <title>Bayer sponsors first Chair for Apparatus Engineering at Dortmund's Technical University</title>
            <link>http://www.medworm.com/index.php?rid=2200322&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2200322</comments>
            <pubDate>Fri, 20 Feb 2009 17:30:00 +0100</pubDate>
            <guid isPermaLink="false">2200322</guid>        </item>
        <item>
            <title>Bayer Schering Pharma to invest 100 million Euro in China to build a global R&amp;D center</title>
            <link>http://www.medworm.com/index.php?rid=2182351&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2182351</comments>
            <pubDate>Thu, 12 Feb 2009 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">2182351</guid>        </item>
        <item>
            <title>Bayer Schering Pharma Starts Phase III Program of New Drug Against Pulmonary Hypertension</title>
            <link>http://www.medworm.com/index.php?rid=2169753&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2169753</comments>
            <pubDate>Mon, 09 Feb 2009 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">2169753</guid>        </item>
        <item>
            <title>Bayer builds world's largest production plant for carbon nanotubes in Chempark Leverkusen</title>
            <link>http://www.medworm.com/index.php?rid=2141264&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2141264</comments>
            <pubDate>Mon, 26 Jan 2009 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">2141264</guid>        </item>
        <item>
            <title>Bayer MaterialScience in talks with employee representatives on the introduction of short-time working</title>
            <link>http://www.medworm.com/index.php?rid=2128772&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2128772</comments>
            <pubDate>Fri, 23 Jan 2009 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">2128772</guid>        </item>
        <item>
            <title>Visanne® - new long-term treatment for endometriosis submitted for registration in Europe</title>
            <link>http://www.medworm.com/index.php?rid=2083888&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2083888</comments>
            <pubDate>Wed, 07 Jan 2009 07:26:56 +0100</pubDate>
            <guid isPermaLink="false">2083888</guid>        </item>
        <item>
            <title>Bayer Strengthens Research and Development</title>
            <link>http://www.medworm.com/index.php?rid=2032948&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2032948</comments>
            <pubDate>Fri, 12 Dec 2008 09:59:00 +0100</pubDate>
            <guid isPermaLink="false">2032948</guid>        </item>
        <item>
            <title>Xarelto® Reduces Symptomatic VTE and Death Following Knee or Hip Replacement Surgery by More Than 50% Compared to Enoxaparin in Pooled Analysis of RECORD Clinical Trial Program</title>
            <link>http://www.medworm.com/index.php?rid=2026751&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2026751</comments>
            <pubDate>Mon, 08 Dec 2008 01:30:00 +0100</pubDate>
            <guid isPermaLink="false">2026751</guid>        </item>
        <item>
            <title>Daniel Hartert to be new Executive Board Chairman of Bayer Business Services GmbH</title>
            <link>http://www.medworm.com/index.php?rid=2026752&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2026752</comments>
            <pubDate>Fri, 05 Dec 2008 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">2026752</guid>        </item>
        <item>
            <title>Bayer named best pharmaceutical and chemical company in Brazil</title>
            <link>http://www.medworm.com/index.php?rid=1955136&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1955136</comments>
            <pubDate>Thu, 13 Nov 2008 10:45:00 +0100</pubDate>
            <guid isPermaLink="false">1955136</guid>        </item>
        <item>
            <title>Professor Berschauer: “Enabling a second green revolution in Asia with new, high-yielding rice varieties”</title>
            <link>http://www.medworm.com/index.php?rid=1946978&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1946978</comments>
            <pubDate>Tue, 11 Nov 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1946978</guid>        </item>
        <item>
            <title>Bayer’s Xarelto® Shows Encouraging Results in Patients with Acute Coronary Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1946979&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1946979</comments>
            <pubDate>Mon, 10 Nov 2008 15:00:00 +0100</pubDate>
            <guid isPermaLink="false">1946979</guid>        </item>
        <item>
            <title>“Environmental Envoys” from 18 countries visit Bayer</title>
            <link>http://www.medworm.com/index.php?rid=1930144&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1930144</comments>
            <pubDate>Tue, 04 Nov 2008 11:30:00 +0100</pubDate>
            <guid isPermaLink="false">1930144</guid>        </item>
        <item>
            <title>Bayer optimistic about future business trend</title>
            <link>http://www.medworm.com/index.php?rid=1914469&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1914469</comments>
            <pubDate>Wed, 29 Oct 2008 07:30:00 +0100</pubDate>
            <guid isPermaLink="false">1914469</guid>        </item>
        <item>
            <title>EUR 150,000 for scholarships and education of teachers</title>
            <link>http://www.medworm.com/index.php?rid=1891889&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1891889</comments>
            <pubDate>Mon, 20 Oct 2008 10:30:00 +0100</pubDate>
            <guid isPermaLink="false">1891889</guid>        </item>
        <item>
            <title>Bayer significantly strengthens its presence in China</title>
            <link>http://www.medworm.com/index.php?rid=1891890&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1891890</comments>
            <pubDate>Fri, 17 Oct 2008 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">1891890</guid>        </item>
        <item>
            <title>First estradiol-based oral contraceptive Qlaira® cleared for market launch in Europe</title>
            <link>http://www.medworm.com/index.php?rid=1891891&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1891891</comments>
            <pubDate>Thu, 16 Oct 2008 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">1891891</guid>        </item>
        <item>
            <title>Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU</title>
            <link>http://www.medworm.com/index.php?rid=1891892&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1891892</comments>
            <pubDate>Wed, 01 Oct 2008 11:15:00 +0100</pubDate>
            <guid isPermaLink="false">1891892</guid>        </item>
        <item>
            <title>Bayer starts new research cooperation in Asia</title>
            <link>http://www.medworm.com/index.php?rid=1891893&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1891893</comments>
            <pubDate>Tue, 30 Sep 2008 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">1891893</guid>        </item>
        <item>
            <title>Five year data confirm that early treatment with Betaferon® at first sign of disease can delay progression to MS</title>
            <link>http://www.medworm.com/index.php?rid=1811243&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1811243</comments>
            <pubDate>Sat, 20 Sep 2008 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">1811243</guid>        </item>
        <item>
            <title>Bayer MaterialScience LLC declares force majeure in the USA</title>
            <link>http://www.medworm.com/index.php?rid=1806133&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1806133</comments>
            <pubDate>Fri, 19 Sep 2008 10:55:32 +0100</pubDate>
            <guid isPermaLink="false">1806133</guid>        </item>
        <item>
            <title>Bayer HealthCare acquires German DIREVO Biotech AG</title>
            <link>http://www.medworm.com/index.php?rid=1794287&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1794287</comments>
            <pubDate>Tue, 16 Sep 2008 08:45:00 +0100</pubDate>
            <guid isPermaLink="false">1794287</guid>        </item>
        <item>
            <title>Bayer’s Xarelto® Approved in Canada</title>
            <link>http://www.medworm.com/index.php?rid=1794288&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1794288</comments>
            <pubDate>Tue, 16 Sep 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1794288</guid>        </item>
        <item>
            <title>The Search is on for the Best Pictures on the Subject of Climate Change</title>
            <link>http://www.medworm.com/index.php?rid=1785780&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1785780</comments>
            <pubDate>Fri, 12 Sep 2008 10:11:00 +0100</pubDate>
            <guid isPermaLink="false">1785780</guid>        </item>
        <item>
            <title>New low-dose oral contraceptive YAZ® launched in Europe</title>
            <link>http://www.medworm.com/index.php?rid=1773147&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1773147</comments>
            <pubDate>Mon, 08 Sep 2008 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">1773147</guid>        </item>
        <item>
            <title>Bayer CropScience plans investment of EUR 3.4 billion in research and development through 2012</title>
            <link>http://www.medworm.com/index.php?rid=1759753&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1759753</comments>
            <pubDate>Thu, 04 Sep 2008 10:30:00 +0100</pubDate>
            <guid isPermaLink="false">1759753</guid>        </item>
        <item>
            <title>Otto Bayer Medals awarded for outstanding research</title>
            <link>http://www.medworm.com/index.php?rid=1759754&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1759754</comments>
            <pubDate>Wed, 03 Sep 2008 16:30:00 +0100</pubDate>
            <guid isPermaLink="false">1759754</guid>        </item>
        <item>
            <title>Sustainable help for earthquake-stricken college in Sichuan</title>
            <link>http://www.medworm.com/index.php?rid=1749978&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1749978</comments>
            <pubDate>Tue, 02 Sep 2008 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">1749978</guid>        </item>
        <item>
            <title>Bayer Submits Recombinant Human Thrombin for European Approval</title>
            <link>http://www.medworm.com/index.php?rid=1749979&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1749979</comments>
            <pubDate>Tue, 02 Sep 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1749979</guid>        </item>
        <item>
            <title>Thiencarbazone-methyl registered in first market</title>
            <link>http://www.medworm.com/index.php?rid=1738929&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1738929</comments>
            <pubDate>Wed, 27 Aug 2008 15:40:00 +0100</pubDate>
            <guid isPermaLink="false">1738929</guid>        </item>
        <item>
            <title>Bayer MaterialScience starts construction of a world-scale TDI plant in Shanghai</title>
            <link>http://www.medworm.com/index.php?rid=1720247&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1720247</comments>
            <pubDate>Thu, 21 Aug 2008 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">1720247</guid>        </item>
        <item>
            <title>Bayer HealthCare and Regeneron Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-related Macular Degeneration</title>
            <link>http://www.medworm.com/index.php?rid=1717050&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1717050</comments>
            <pubDate>Tue, 19 Aug 2008 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">1717050</guid>        </item>
        <item>
            <title>Bayer’s Annual Report Receives International Praise</title>
            <link>http://www.medworm.com/index.php?rid=1700546&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1700546</comments>
            <pubDate>Tue, 12 Aug 2008 13:30:00 +0100</pubDate>
            <guid isPermaLink="false">1700546</guid>        </item>
        <item>
            <title>Bayer appoints Greg Babe as new CEO for U.S. Organisation</title>
            <link>http://www.medworm.com/index.php?rid=1671417&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1671417</comments>
            <pubDate>Thu, 31 Jul 2008 14:30:00 +0100</pubDate>
            <guid isPermaLink="false">1671417</guid>        </item>
        <item>
            <title>Bayer continues its success</title>
            <link>http://www.medworm.com/index.php?rid=1664019&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1664019</comments>
            <pubDate>Wed, 30 Jul 2008 07:30:00 +0100</pubDate>
            <guid isPermaLink="false">1664019</guid>        </item>
        <item>
            <title>Bayer’s Novel Anticoagulant Rivaroxaban Submitted for Approval in the U.S.</title>
            <link>http://www.medworm.com/index.php?rid=1664020&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1664020</comments>
            <pubDate>Wed, 30 Jul 2008 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">1664020</guid>        </item>
        <item>
            <title>Nexavar Approved for Treatment of Liver Cancer in China</title>
            <link>http://www.medworm.com/index.php?rid=1658066&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1658066</comments>
            <pubDate>Mon, 28 Jul 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1658066</guid>        </item>
        <item>
            <title>Bayer’s Novel Anticoagulant Rivaroxaban Recommended for Approval in the EU</title>
            <link>http://www.medworm.com/index.php?rid=1652221&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1652221</comments>
            <pubDate>Fri, 25 Jul 2008 09:32:48 +0100</pubDate>
            <guid isPermaLink="false">1652221</guid>        </item>
        <item>
            <title>Andreas Fibig named new Chairman of the Board of Management of Bayer Schering Pharma</title>
            <link>http://www.medworm.com/index.php?rid=1652222&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1652222</comments>
            <pubDate>Fri, 25 Jul 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1652222</guid>        </item>
        <item>
            <title>Tembotrione from Bayer CropScience approved in Brazil</title>
            <link>http://www.medworm.com/index.php?rid=1596242&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1596242</comments>
            <pubDate>Tue, 08 Jul 2008 15:45:00 +0100</pubDate>
            <guid isPermaLink="false">1596242</guid>        </item>
        <item>
            <title>Bayer HealthCare Completes Acquisition of Western OTC Cough and Cold Business of Topsun Science and Technology</title>
            <link>http://www.medworm.com/index.php?rid=1560582&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1560582</comments>
            <pubDate>Wed, 02 Jul 2008 08:50:16 +0100</pubDate>
            <guid isPermaLink="false">1560582</guid>        </item>
        <item>
            <title>Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen</title>
            <link>http://www.medworm.com/index.php?rid=1560583&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1560583</comments>
            <pubDate>Wed, 02 Jul 2008 08:25:00 +0100</pubDate>
            <guid isPermaLink="false">1560583</guid>        </item>
        <item>
            <title>Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States</title>
            <link>http://www.medworm.com/index.php?rid=1542917&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1542917</comments>
            <pubDate>Tue, 24 Jun 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1542917</guid>        </item>
        <item>
            <title>Bayer plans to invest EUR 100 million in Brazil</title>
            <link>http://www.medworm.com/index.php?rid=1537801&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1537801</comments>
            <pubDate>Mon, 23 Jun 2008 15:25:00 +0100</pubDate>
            <guid isPermaLink="false">1537801</guid>        </item>
        <item>
            <title>Bayer receives Environmental Award from the Federation of German Industries</title>
            <link>http://www.medworm.com/index.php?rid=1537802&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1537802</comments>
            <pubDate>Mon, 23 Jun 2008 14:20:00 +0100</pubDate>
            <guid isPermaLink="false">1537802</guid>        </item>
        <item>
            <title>Bayer CEO Werner Wenning receives prestigious McCloy Award</title>
            <link>http://www.medworm.com/index.php?rid=1530992&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1530992</comments>
            <pubDate>Fri, 20 Jun 2008 09:30:00 +0100</pubDate>
            <guid isPermaLink="false">1530992</guid>        </item>
        <item>
            <title>Bayer will use tobacco plants to produce medicines</title>
            <link>http://www.medworm.com/index.php?rid=1521892&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1521892</comments>
            <pubDate>Mon, 16 Jun 2008 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">1521892</guid>        </item>
        <item>
            <title>Bayer Climate Program makes great advances</title>
            <link>http://www.medworm.com/index.php?rid=1502438&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1502438</comments>
            <pubDate>Mon, 09 Jun 2008 10:33:00 +0100</pubDate>
            <guid isPermaLink="false">1502438</guid>        </item>
        <item>
            <title>European Journalists’ Prize goes to Poland and Germany</title>
            <link>http://www.medworm.com/index.php?rid=1494209&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1494209</comments>
            <pubDate>Thu, 05 Jun 2008 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">1494209</guid>        </item>
        <item>
            <title>Bayer HealthCare Commits US-Dollar 2.5 Million in Funding to Advance Global Hemophilia Research and Patient Care</title>
            <link>http://www.medworm.com/index.php?rid=1488015&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1488015</comments>
            <pubDate>Tue, 03 Jun 2008 10:00:00 +0100</pubDate>
            <guid isPermaLink="false">1488015</guid>        </item>
        <item>
            <title>Bayer HealthCare successfully completes acquisition of Sagmel, Inc.’s OTC Business</title>
            <link>http://www.medworm.com/index.php?rid=1488016&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1488016</comments>
            <pubDate>Tue, 03 Jun 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1488016</guid>        </item>
        <item>
            <title>Rivaroxaban One Tablet/Once-Daily Superior to Twice-Daily Injectable Enoxaparin in Preventing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial</title>
            <link>http://www.medworm.com/index.php?rid=1477775&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1477775</comments>
            <pubDate>Fri, 30 May 2008 13:00:00 +0100</pubDate>
            <guid isPermaLink="false">1477775</guid>        </item>
        <item>
            <title>Bayer increases aid to disaster victims in China and Burma</title>
            <link>http://www.medworm.com/index.php?rid=1477776&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1477776</comments>
            <pubDate>Fri, 30 May 2008 12:15:00 +0100</pubDate>
            <guid isPermaLink="false">1477776</guid>        </item>
        <item>
            <title>Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent</title>
            <link>http://www.medworm.com/index.php?rid=1445857&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1445857</comments>
            <pubDate>Fri, 16 May 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1445857</guid>        </item>
        <item>
            <title>Bayer to Help Victims of Natural Disasters in China and Burma</title>
            <link>http://www.medworm.com/index.php?rid=1442650&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1442650</comments>
            <pubDate>Thu, 15 May 2008 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">1442650</guid>        </item>
        <item>
            <title>Bayer lays the foundation for its zero-emission building in India</title>
            <link>http://www.medworm.com/index.php?rid=1439415&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1439415</comments>
            <pubDate>Tue, 13 May 2008 11:30:00 +0100</pubDate>
            <guid isPermaLink="false">1439415</guid>        </item>
        <item>
            <title>Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye in Wet Age-related Macular Degeneration</title>
            <link>http://www.medworm.com/index.php?rid=1428894&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1428894</comments>
            <pubDate>Thu, 08 May 2008 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">1428894</guid>        </item>
        <item>
            <title>Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe</title>
            <link>http://www.medworm.com/index.php?rid=1422966&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1422966</comments>
            <pubDate>Tue, 06 May 2008 08:30:00 +0100</pubDate>
            <guid isPermaLink="false">1422966</guid>        </item>
        <item>
            <title>“2007 was Bayer’s most successful year to date”</title>
            <link>http://www.medworm.com/index.php?rid=1397574&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1397574</comments>
            <pubDate>Fri, 25 Apr 2008 09:52:54 +0100</pubDate>
            <guid isPermaLink="false">1397574</guid>        </item>
        <item>
            <title>Bayer off to an excellent start in 2008</title>
            <link>http://www.medworm.com/index.php?rid=1395059&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1395059</comments>
            <pubDate>Thu, 24 Apr 2008 07:30:00 +0100</pubDate>
            <guid isPermaLink="false">1395059</guid>        </item>
        <item>
            <title>Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®</title>
            <link>http://www.medworm.com/index.php?rid=1388856&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1388856</comments>
            <pubDate>Mon, 21 Apr 2008 18:00:00 +0100</pubDate>
            <guid isPermaLink="false">1388856</guid>        </item>
        <item>
            <title>Bayer donates €250,000 for patients with hemophilia and provides nearly 1 million international units of Kogenate®</title>
            <link>http://www.medworm.com/index.php?rid=1377911&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1377911</comments>
            <pubDate>Thu, 17 Apr 2008 09:11:01 +0100</pubDate>
            <guid isPermaLink="false">1377911</guid>        </item>
        <item>
            <title>Bayer HealthCare Affiliate MEDRAD Announces Completion of Subsequent Offering Period for Shares of Possis Medical</title>
            <link>http://www.medworm.com/index.php?rid=1362347&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1362347</comments>
            <pubDate>Wed, 02 Apr 2008 14:30:00 +0100</pubDate>
            <guid isPermaLink="false">1362347</guid>        </item>
        <item>
            <title>Bayer appeals invalidity ruling on its Yasmin® Patent</title>
            <link>http://www.medworm.com/index.php?rid=1362348&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1362348</comments>
            <pubDate>Mon, 31 Mar 2008 19:08:00 +0100</pubDate>
            <guid isPermaLink="false">1362348</guid>        </item>
        <item>
            <title>Zevalin® Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment</title>
            <link>http://www.medworm.com/index.php?rid=1362349&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1362349</comments>
            <pubDate>Thu, 20 Mar 2008 16:35:00 +0100</pubDate>
            <guid isPermaLink="false">1362349</guid>        </item>
        <item>
            <title>Bayer HealthCare to acquire OTC Business of Sagmel, Inc.</title>
            <link>http://www.medworm.com/index.php?rid=1292178&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1292178</comments>
            <pubDate>Tue, 11 Mar 2008 07:55:33 +0100</pubDate>
            <guid isPermaLink="false">1292178</guid>        </item>
        <item>
            <title>Court decides against Bayer’s Yasmin® patent</title>
            <link>http://www.medworm.com/index.php?rid=1275955&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1275955</comments>
            <pubDate>Mon, 03 Mar 2008 22:21:00 +0100</pubDate>
            <guid isPermaLink="false">1275955</guid>        </item>
        <item>
            <title>Wenning: 2007 was Bayer’s most successful year to date</title>
            <link>http://www.medworm.com/index.php?rid=1263342&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1263342</comments>
            <pubDate>Thu, 28 Feb 2008 07:30:00 +0100</pubDate>
            <guid isPermaLink="false">1263342</guid>        </item>
        <item>
            <title>Bayer proposes increased dividend for 2007 of EUR 1.35 per share</title>
            <link>http://www.medworm.com/index.php?rid=1258030&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1258030</comments>
            <pubDate>Tue, 26 Feb 2008 11:15:00 +0100</pubDate>
            <guid isPermaLink="false">1258030</guid>        </item>
        <item>
            <title>Bayer will vigorously defend itself against Kogenate patent infringement suit filed by Novartis</title>
            <link>http://www.medworm.com/index.php?rid=1244968&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1244968</comments>
            <pubDate>Wed, 20 Feb 2008 16:30:00 +0100</pubDate>
            <guid isPermaLink="false">1244968</guid>        </item>
        <item>
            <title>Bayer and Onyx Provide Update on Phase III Trial of Nexavar® in Patients with Non-Small Cell Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1239170&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1239170</comments>
            <pubDate>Mon, 18 Feb 2008 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">1239170</guid>        </item>
        <item>
            <title>Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement</title>
            <link>http://www.medworm.com/index.php?rid=1222269&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1222269</comments>
            <pubDate>Mon, 11 Feb 2008 13:30:00 +0100</pubDate>
            <guid isPermaLink="false">1222269</guid>        </item>
        <item>
            <title>Nexavar® Approved for the Treatment of Kidney Cancer in Japan</title>
            <link>http://www.medworm.com/index.php?rid=1181598&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1181598</comments>
            <pubDate>Mon, 28 Jan 2008 03:00:00 +0100</pubDate>
            <guid isPermaLink="false">1181598</guid>        </item>
        <item>
            <title>Bayer extends product portfolio for liver cancer patients in Japan</title>
            <link>http://www.medworm.com/index.php?rid=1173020&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1173020</comments>
            <pubDate>Thu, 24 Jan 2008 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">1173020</guid>        </item>
        <item>
            <title>Bayer establishes US special access program for Leukine® while replacing current liquid formulation</title>
            <link>http://www.medworm.com/index.php?rid=1173021&amp;cid=s_34530_34_f&amp;fid=34530&amp;url=http%3A%2F%2Fwww.bayer.com</link>
            <description>(Source: Bayer Company News)</description>
            <author>Bayer Company News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1173021</comments>
            <pubDate>Wed, 23 Jan 2008 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">1173021</guid>        </item>
    </channel>
</rss>
